The dimeric KPV peptide (CKPV)2 potently inhibited LPS-induced inflammatory responses in mice, including fever, cytokine release, and organ damage — demonstrating enhanced anti-inflammatory efficacy from the dimerized KPV scaffold.
Key findingDimeric KPV peptide (CKPV)2 inhibited endotoxin-induced host responses including fever, TNF-α/IL-6 release, and organ damage in mice, with enhanced an
What the researchers found
Dimeric KPV peptide (CKPV)2 inhibited endotoxin-induced host responses including fever, TNF-α/IL-6 release, and organ damage in mice, with enhanced anti-inflammatory potency compared to monomeric alpha-MSH — demonstrating improved efficacy through KPV dimerization.
Why it matters
Relevant for kpv, inflammation, infection.
How the study worked
animal-study study on kpv, inflammation.
What this study cannot tell us
See abstract.
How to read the evidence
moderate evidence.
When this study was published
Published in 2006.
The bigger picture
Advances peptide research.
Questions still open
- Further research needed.
- Clinical translation to evaluate.
Common questions
What was studied?
What was found?
Read the original research
Inhibitory effects of the peptide (CKPV)2 on endotoxin-induced host reactions.
The Journal of surgical research, 131(2), 209-14
Citation
Gatti, Stefano; Carlin, Andrea; Sordi, Andrea; Leonardi, Patrizia; Colombo, Gualtiero; Fassati, Luigi R; Lipton, James M; Catania, Anna. (2006). Inhibitory effects of the peptide (CKPV)2 on endotoxin-induced host reactions.. The Journal of surgical research, 131(2), 209-14.